Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CERo Therapeutics Holdings, Inc. - Common Stock (NQ:CERO)

0.0951 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CERo Therapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Announces Listing on OTC Markets
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened
Via Stocktwits
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Top movers in Thursday's after hours session
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Progresses Phase 1 CER-1236 AML Trial with Dosing of Third Patient in Initial Dose Cohort
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing In Q3
 
Via Benzinga
CERo Therapeutics Receives Notice of Allowance from U.S. Patent and Trade Office on Composition of Matter and Method of Use for CER-1236 in Cancer with Expected Protection Through 2041
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
CERo Therapeutics Announces Dose Intensification in Phase 1 Study of CER-1236 in Acute Myeloid Leukemia
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML)
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Top movers in Monday's after hours session
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Dow Surges 150 Points; Korn Ferry Earnings Top Views
 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.